PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+10.02%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$999M
AUM Growth
+$999M
(+12%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
13.13%
Top 10 Holdings %
Top 10 Hldgs %
48.3%
Holding
166
New
40
Increased
25
Reduced
29
Closed
47
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$38M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$34.4M |
| 3 |
Insmed
INSM
|
$29.2M |
| 4 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$28.7M |
| 5 |
Zimmer Biomet
ZBH
|
$25.2M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$21.5M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$18.5M |
| 3 |
Exact Sciences
EXAS
|
$15.7M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$10.6M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$10.4M |
Sector Composition
| 1 | Healthcare | 84.97% |
| 2 | Financials | 1.08% |
| 3 | Consumer Discretionary | 0.01% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sangamo Therapeutics
SGMO
$161M
| $12.2M | 1.2% |
800,000
| – | – |
|
|
AVDL
27
Avadel Pharmaceuticals
AVDL
$1.42B
| $12M | 1.18% |
800,000
| – | – |
|
28
HCA Healthcare
HCA
$95.4B
| $11.2M | 1.09% |
197,806
+47,806
| +32% | +$2.7M |
|
29
Prothena Corp
PRTA
$452M
| $10.9M | 1.07% |
483,162
+133,162
| +38% | +$3M |
|
|
AET
30
DELISTED
Aetna Inc
AET
| $10.6M | 1.04% |
+131,308
| New | +$10.6M |
|
|
XLRN
31
DELISTED
Acceleron Pharma Inc.
XLRN
| $10.2M | 1% |
+300,000
| New | +$10.2M |
|
32
MacroGenics
MGNX
$121M
| $9.38M | 0.92% |
431,803
-17,142
| -4% | -$372K |
|
|
ANAC
33
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $9.38M | 0.92% |
528,776
-118,239
| -18% | -$2.1M |
|
|
ITMN
34
DELISTED
INTERMUNE INC
ITMN
| $9.27M | 0.91% |
210,000
-50,000
| -19% | -$2.21M |
|
|
ARAV
35
DELISTED
Aravive, Inc. Common Stock
ARAV
| $8.86M | 0.87% |
52,633
-30,911
| -37% | -$5.2M |
|
|
RCPT
36
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $8.73M | 0.86% |
205,000
+170,000
| +486% | +$7.24M |
|
|
AGN
37
DELISTED
ALLERGAN INC
AGN
| $8.46M | 0.83% |
+50,000
| New | +$8.46M |
|
|
BDSI
38
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $8.45M | 0.83% |
700,000
+510,000
| +268% | +$6.16M |
|
39
Medtronic
MDT
$118B
| $8.29M | 0.81% |
+130,000
| New | +$8.29M |
|
|
ASXC
40
DELISTED
Asensus Surgical, Inc.
ASXC
| $6.55M | 0.64% |
+100,000
| New | +$6.55M |
|
41
Arrowhead Research
ARWR
$3.84B
| $6.05M | 0.59% |
422,406
+105,106
| +33% | +$1.5M |
|
|
TBRA
42
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $5.84M | 0.57% |
+95,556
| New | +$5.84M |
|
|
SPNC
43
DELISTED
Spectranetics Corp
SPNC
| $5.57M | 0.55% |
243,354
-89,200
| -27% | -$2.04M |
|
|
DSCI
44
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $4.7M | 0.46% |
406,437
-126,363
| -24% | -$1.46M |
|
45
Centene
CNC
$14.8B
| $4.54M | 0.45% |
240,000
+229,560
| +2,199% | +$4.34M |
|
|
TRVN
46
DELISTED
Trevena, Inc.
TRVN
| $4.35M | 0.43% |
1,232
| – | – |
|
|
AERI
47
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.2M | 0.41% |
1,121,951
+910,433
| +430% | +$3.4M |
|
48
Catalyst Pharmaceutical
CPRX
$2.42B
| $3.8M | 0.37% |
+1,500,000
| New | +$3.8M |
|
|
AGTC
49
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.4M | 0.33% |
+146,978
| New | +$3.4M |
|
|
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
| $3.24M | 0.32% |
148,000
+8,000
| +6% | +$175K |
|